Trade NeoGenomics - NEOus CFD
Add to favourite- Summary
- Historical Data
Spread | 0.11 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023374% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001151% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 16.33 |
Open | 16.31 |
1-Year Change | -18.25% |
Day's Range | 16.17 - 16.52 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 20, 2024 | 16.36 | 0.20 | 1.24% | 16.16 | 16.54 | 16.16 |
Dec 19, 2024 | 16.33 | -0.06 | -0.37% | 16.39 | 16.76 | 16.18 |
Dec 18, 2024 | 16.44 | -1.09 | -6.22% | 17.53 | 17.71 | 16.36 |
Dec 17, 2024 | 17.49 | 0.00 | 0.00% | 17.49 | 17.78 | 17.29 |
Dec 16, 2024 | 17.90 | 0.32 | 1.82% | 17.58 | 18.12 | 17.15 |
Dec 13, 2024 | 17.67 | -0.04 | -0.23% | 17.71 | 17.92 | 17.43 |
Dec 12, 2024 | 17.85 | -0.14 | -0.78% | 17.99 | 18.42 | 17.82 |
Dec 11, 2024 | 18.12 | -0.27 | -1.47% | 18.39 | 18.61 | 18.12 |
Dec 10, 2024 | 18.38 | 0.49 | 2.74% | 17.89 | 18.94 | 17.89 |
Dec 9, 2024 | 17.87 | 0.09 | 0.51% | 17.78 | 18.23 | 17.77 |
Dec 6, 2024 | 17.70 | 0.41 | 2.37% | 17.29 | 17.95 | 17.27 |
Dec 5, 2024 | 17.15 | -0.61 | -3.43% | 17.76 | 17.86 | 17.13 |
Dec 4, 2024 | 17.95 | 0.44 | 2.51% | 17.51 | 18.31 | 17.46 |
Dec 3, 2024 | 17.78 | 0.05 | 0.28% | 17.73 | 17.97 | 17.53 |
Dec 2, 2024 | 17.93 | 0.20 | 1.13% | 17.73 | 18.02 | 17.38 |
Nov 29, 2024 | 17.69 | 0.00 | 0.00% | 17.69 | 17.91 | 17.50 |
Nov 27, 2024 | 17.68 | 0.54 | 3.15% | 17.14 | 17.73 | 17.14 |
Nov 26, 2024 | 17.13 | 0.22 | 1.30% | 16.91 | 17.13 | 16.51 |
Nov 25, 2024 | 16.87 | 0.46 | 2.80% | 16.41 | 17.13 | 16.41 |
Nov 22, 2024 | 16.32 | 1.18 | 7.79% | 15.14 | 16.39 | 15.14 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
NeoGenomics Company profile
About NeoGenomics, Inc.
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories. The Company operates through two segments: the Clinical Services Segment and the Pharma Services Segment. The Clinical Services segment provides various clinical testing services to community-based pathology practices, oncology practices, hospital pathology labs, reference labs, and academic centers with reimbursement from various payers, including client direct billing, commercial insurance, Medicare and other government payers, and patients. The Pharma Services segment supports pharmaceutical firms in their drug development programs by providing testing services and data analytics for clinical trials and research. It offers testing services, which include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, immunohistochemistry (IHC) and digital imaging, molecular testing and morphologic analysis. It operates testing laboratories in United States, Europe and Asia.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, NeoGenomics, Inc. revenues increased 9% to $484.3M. Net loss totaled $8.3M vs. income of $4.2M. Revenues reflect Clinical Services segment increase of 6% to $404.2M, Pharma Services segment increase of 29% to $80.2M. Net loss reflects General and administrative increase of 38% to $167.2M (expense), Sales and marketing increase of 31% to $62.6M (expense).
Equity composition
Common Stock $0.001 Par, 03/12, 100M auth., 43,236,498. issd. Insiders own approx. 46.49%.
Industry: | Medical & Diagnostic Laboratories |
9490 Neogenomics Way
FORT MYERS
FLORIDA 33912
US
News
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
22:39, 12 December 2024Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
12:47, 5 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com